ALS (also known as Lou Gehrig's Disease) is a progressive neuromuscular disease in which nerve cells die and leave voluntary muscles paralyzed.

Every day two or three Canadians die of the disease.

Learn More About ALS

Help end ALS

 

    

 

 

 

ALS News

Highlights from Research Breakthroughs in 2011:

A Landmark Year in the History of ALS Research

While advances in ALS research over the past 3 years have been outstanding, 2011 was a year of multiple exciting breakthroughs many are calling a true turning point for ALS research worldwide. These new findings build on steady advances in fields as diverse as biomarkers

Read More »
Join the LINC Study

Are you or someone you know living with a neurological condition? If so, join the LINC Study today.  This national study is designed to help researchers learn about the impact of living with a neurological condition.

Read More »
Operating Grant: Winter 2012 Priority Announcement (Specific Research Areas)

CIHR - Operating Grant: Winter 2012 Priority Announcement (Specific Research Areas)

Read More »
Effects of Vitamin D deficiency in a transgenic mouse model of ALS

A new York University research study yielded conflicting results about the effects of dietary deficiency of Vitamin D from an early age in the well-characterized G93A (mutant SOD-1) transgenic mouse

Read More »
Irish neurologist awarded for ALS/Motor Neuron Disease research

Professor Orla Hardiman, Consultant Neurologist at Beaumont Hospital, and Clinical Professor of Neurology in Trinity College Dublin, has been awarded the 2011 Forbes Norris Award.

Read More »
Tilson Reintroduces Bill to Designate

OTTAWA – David Tilson, Member of Parliament for Dufferin-Caledon, rose in the House of Commons today to reintroduce his Private Member’s Bill that would designate June as Amyotrophic Lateral Sclerosis (also known as ALS or Lou Gehrig’s disease) Month. 

Read More »
All News